CarbaMic acid, N-Methyl-N-[(3R,4R)-4-Methyl- 3-piperidinyl]-, 1,1-diMethylethyl ester, rel-
- $845 - $1386
- Product name: CarbaMic acid, N-Methyl-N-[(3R,4R)-4-Methyl- 3-piperidinyl]-, 1,1-diMethylethyl ester, rel-
- CAS: 1206824-89-6
- MF: C12H24N2O2
- MW: 228.33
- EINECS:
- MDL Number:MFCD09475549
- Synonyms:CarbaMic acid, N-Methyl-N-[(3R,4R)-4-Methyl- 3-piperidinyl]-, 1,1-diMethylethyl ester, rel-;tert-butyl methyl((3R,4R)-4-methylpiperidin-3-yl)carbamate;tert-butyl N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]carbamate;(3R,4R)-3-(N-BOC-N-METHYLAMINO)-4-METHYLPIPERIDINE;rel-tert-Butyl methyl((3R,4R)-4-methylpiperidin-3-yl)carbamate
3 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 1g
- ManufacturerChemenu
- Product numberCM302879
- Product descriptiontert-Butylmethyl((3R,4R)-4-methylpiperidin-3-yl)carbamate 95%
- Packaging1g
- Price$845
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11332118
- Product descriptiontert-Butylmethyl((3R,4R)-4-methylpiperidin-3-yl)carbamate 95+%
- Packaging1g
- Price$896
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number124965
- Product descriptiontert-Butylmethyl((3R,4R)-4-methylpiperidin-3-yl)carbamate 95+%
- Packaging1g
- Price$1386
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM302879 | tert-Butylmethyl((3R,4R)-4-methylpiperidin-3-yl)carbamate 95% | 1g | $845 | 2021-12-16 | Buy |
Crysdot | CD11332118 | tert-Butylmethyl((3R,4R)-4-methylpiperidin-3-yl)carbamate 95+% | 1g | $896 | 2021-12-16 | Buy |
Matrix Scientific | 124965 | tert-Butylmethyl((3R,4R)-4-methylpiperidin-3-yl)carbamate 95+% | 1g | $1386 | 2021-12-16 | Buy |
Properties
Boiling point :298.5±29.0 °C(Predicted)
Density :1.00±0.1 g/cm3(Predicted)
pka :9.98±0.10(Predicted)
Density :1.00±0.1 g/cm3(Predicted)
pka :9.98±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|